Infliximab: getting the most for your money.
Irving
Peter M
PM
Gibson
Peter R
PR
D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use*; D016527:Drug Costs / Q000706:statistics & numerical data; D005765:Gastrointestinal Agents / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D018579:Patient Selection
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab